Deals
Fibrocell Science Secures $50M ATM via Cantor Fitzgerald & Company
|
Fibrocell Science (NASDAQ CM:FCSC) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction
Growth Capitalist (https://growthcapitalist.com/tag/biotech/page/14/)
Fibrocell Science (NASDAQ CM:FCSC) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction
JMP Group’s (JMP) Harvest Capital Strategies unit recently raised $245 million for a fund that will exclusively investment in companies using biotechnology developed by Intrexon Corp. (XON).
ContraFect Corporation (NASDAQ CM:CFRX) announced that it has secured up to $30,000,000 in an ATM (At the Market) transaction.
Parnell Pharmaceuticals Holdings Limited (NASDAQ GM:PARN) announced that it has secured up to $15,000,000 in a Structured Equity Line transaction.